Mellitofix Trio 25/5/1000 mg 30 tablets
Eva Pharma
Eva Pharma
Overview
Mellitofix Trio 25/5/1000 mg is a fixed-dose combination tablet for type 2 diabetes management, bringing together empagliflozin, linagliptin, and extended-release metformin in a single once-daily dose.
Key Benefits
The combination pairs an SGLT2 inhibitor (empagliflozin 25 mg) and a DPP-4 inhibitor (linagliptin 5 mg) with a biguanide (metformin extended-release 1000 mg), working through three mechanisms to support glycemic control. Used as an adjunct to diet and exercise in adults with type 2 diabetes when combination therapy is appropriate; not indicated for type 1 diabetes or ketoacidosis.
How to Use
Take orally once daily with a meal. Swallow the tablet whole; do not split, crush, or chew it. Dosing should follow your physician's guidance, based on prior therapy, metformin tolerability, and kidney function.
Active Ingredients
Empagliflozin 25 mg, linagliptin 5 mg, metformin hydrochloride (extended-release) 1000 mg.
Precautions
Contraindicated in hypersensitivity to any active substance or excipient, and in severe renal impairment. Kidney function should be assessed before and periodically during treatment. Use only under medical supervision.
Storage
Store in a cool, dry place below 25°C, away from direct sunlight and out of reach of children.